Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Steuber

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Urologic Oncology|November 3, 2009
Prostate cancer in the elderlyHans Heinzer, Thomas Steuber
World Journal of Urology|March 9, 2007
Circulating biomarkers for prostate cancerThomas Steuber, Pauliina Helo, Hans Lilja
Current Opinion in Urology|August 22, 2017
Radical prostatectomy in oligometastatic prostate cancerPhilipp Mandel, Thomas Steuber, Markus Graefen
Urologie (Heidelberg, Germany)|February 8, 2024
[Local therapies for oligometastatic hormone-sensitive prostate cancer]Fabian Falkenbach, Thomas Steuber, Markus Graefen
European Urology|February 5, 2008
Serum markers for prostate cancer: a rational approach to the literatureThomas Steuber, Matthew Frank O'Brien, Hans Lilja
Nature|October 28, 2005
Low-latitude seasonality of Cretaceous temperatures in warm and cold episodesThomas Steuber, Markus Rauch, Jean-Pierre Masse, et al.
Cancer|January 10, 2006
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomyThomas Steuber, Andreas Erbersdobler, Markus Graefen, et al.
Plos One|November 12, 2021
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathologyAlcibiade Athanasiou, Pierre Tennstedt, Anja Wittig, et al.
World Journal of Urology|September 13, 2019
Outcome of patients with newly diagnosed prostate cancer with low metastatic burden treated with radical prostatectomy: a comparison to STAMPEDE arm HSophie Knipper, Burkhard Beyer, Philipp Mandel, et al.
The Journal of Urology|October 24, 2002
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigenThomas Steuber, Paulina Nurmikko, Alexander Haese, et al.
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Urologic Oncology|November 3, 2009
Prostate cancer in the elderlyHans Heinzer, Thomas Steuber
World Journal of Urology|March 9, 2007
Circulating biomarkers for prostate cancerThomas Steuber, Pauliina Helo, Hans Lilja
Current Opinion in Urology|August 22, 2017
Radical prostatectomy in oligometastatic prostate cancerPhilipp Mandel, Thomas Steuber, Markus Graefen
Urologie (Heidelberg, Germany)|February 8, 2024
[Local therapies for oligometastatic hormone-sensitive prostate cancer]Fabian Falkenbach, Thomas Steuber, Markus Graefen
European Urology|February 5, 2008
Serum markers for prostate cancer: a rational approach to the literatureThomas Steuber, Matthew Frank O'Brien, Hans Lilja
Nature|October 28, 2005
Low-latitude seasonality of Cretaceous temperatures in warm and cold episodesThomas Steuber, Markus Rauch, Jean-Pierre Masse, et al.
Cancer|January 10, 2006
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomyThomas Steuber, Andreas Erbersdobler, Markus Graefen, et al.
Plos One|November 12, 2021
A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathologyAlcibiade Athanasiou, Pierre Tennstedt, Anja Wittig, et al.
World Journal of Urology|September 13, 2019
Outcome of patients with newly diagnosed prostate cancer with low metastatic burden treated with radical prostatectomy: a comparison to STAMPEDE arm HSophie Knipper, Burkhard Beyer, Philipp Mandel, et al.
The Journal of Urology|October 24, 2002
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigenThomas Steuber, Paulina Nurmikko, Alexander Haese, et al.
Pageof 21